DaVita Inc. (NYSE:DVA) Shares Bought by ProShare Advisors LLC

ProShare Advisors LLC lifted its stake in shares of DaVita Inc. (NYSE:DVA) by 3.7% during the second quarter, Holdings Channel reports. The fund owned 7,537 shares of the company’s stock after purchasing an additional 268 shares during the quarter. ProShare Advisors LLC’s holdings in DaVita were worth $1,044,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DVA. Blue Trust Inc. boosted its stake in shares of DaVita by 58.6% during the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after purchasing an additional 78 shares during the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in DaVita during the fourth quarter worth approximately $30,000. Family Firm Inc. purchased a new stake in DaVita in the 2nd quarter worth approximately $43,000. Versant Capital Management Inc raised its holdings in DaVita by 90.6% in the 2nd quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock valued at $45,000 after acquiring an additional 155 shares during the last quarter. Finally, Friedenthal Financial purchased a new position in shares of DaVita during the 2nd quarter worth $48,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 0.5 %

DVA opened at $163.08 on Friday. The firm has a 50 day moving average price of $150.14 and a 200 day moving average price of $142.11. DaVita Inc. has a 1 year low of $71.51 and a 1 year high of $166.04. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16. The company has a market cap of $14.30 billion, a PE ratio of 18.53, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, August 6th. The company reported $2.59 EPS for the quarter, beating the consensus estimate of $2.47 by $0.12. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.15 billion. During the same period last year, the business posted $2.08 EPS. The company’s revenue was up 6.2% on a year-over-year basis. Sell-side analysts expect that DaVita Inc. will post 9.99 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Truist Financial upped their target price on DaVita from $150.00 to $165.00 and gave the company a “hold” rating in a research note on Tuesday, August 20th. Bank of America increased their price objective on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a report on Wednesday, August 7th. TD Cowen boosted their target price on shares of DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a report on Wednesday, July 24th. UBS Group increased their price target on shares of DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Finally, StockNews.com cut shares of DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 8th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, DaVita currently has a consensus rating of “Hold” and an average price target of $157.00.

Insider Buying and Selling at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the transaction, the insider now directly owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the sale, the insider now owns 83,011 shares in the company, valued at $12,137,038.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, COO Michael David Staffieri sold 9,539 shares of the firm’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $150.03, for a total value of $1,431,136.17. Following the transaction, the chief operating officer now owns 241,945 shares in the company, valued at $36,299,008.35. The disclosure for this sale can be found here. Insiders sold a total of 173,482 shares of company stock valued at $27,387,069 in the last ninety days. Insiders own 2.00% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.